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Activated intrarenal transcription of CTL-effectors and TGF-1 The vast majority of childhood nephrotic syndrome
in children with focal segmental glomerulosclerosis. (NS) is caused by minimal change disease (MCD) or focal
Background. The pathogenesis of childhood nephrotic syn- segmental glomerulosclerosis (FSGS). MCD, though of-drome (NS), whether the lesion is minimal change disease (MCD)
ten protracted, is a benign disease, whereas FSGS has aor focal segmental glomerulosclerosis (FSGS), remains elusive.
relentless progression to end-stage renal disease (ESRD)Based on the presence of elevated cytokine levels in peripheral
blood, a T cell-induced injury could be postulated. in most cases [1] and is the most common glomerular
Methods. To test the hypothesis that infiltrating T cells ac- lesion in children that leads to either dialysis or trans-
tively contribute to the glomerular injury in children with NS, plantation [2]. As the initial clinical presentation of these
we studied the intrarenal transcription of various T cell-related
two lesions is similar and no specific clinical or laboratorychemokines, cytokines and cytotoxic T-lymphocyte (CTL) effec-
parameters exist to distinguish lesions, often only a path-tor molecules in the renal biopsy tissue of 52 nephrotic children
with a variety of histologic lesions. Intrarenal gene expression ologic evaluation of renal tissue will establish this critical
was studied using reverse transcription (RT)-assisted–polymer- distinction [3]. However, in early stages critical for inter-
ase chain reaction (PCR). vention even a thorough pathologic evaluation may be
Results. Interleukin-2 (IL-2) and IL-4 transcripts were not ob-
indecisive [4]. More recently it has been advocated thatserved in any of the specimens. IL-2 receptor alpha mRNA
it is not histology, but nonresponse to corticosteroid andwas detected in 24 of 40 proteinuric patients, but also in 6 of
cyclosporine (CsA) treatment that is a decisive indicator10 patients in remission and showed no significant differences
with regard to steroid response. Intrarenal gene expression of of progressive disease [5].
CTL mediators and transforming growth factor-1 (TGF-1) Lymphocyte-mediated immune mechanisms, namely
was noted particularly in patients with progressive disease lead- T cells, have been implicated in the genesis of nephroticing to chronic renal failure. TGF-1 gene expression was noted
syndrome since 1974 [6]. To date it remains unclear whe-in 23 of 29 steroid resistant (SR) children with NS not caused
ther the observed peripheral blood cytokine release [7–9]by lupus nephritis and in 18 of 20 FSGS patients. In contrast
TGF-1 gene expression was detected in only 3 of 14 steroid- and up-regulation of soluble -receptors [8, 10, 11] are
sensitive patients (P  0.001). Two of these patients later postinfectious epiphenomena or indicators of immuno-
developed FSGS. In patients with steroid-resistant NS, intra- logically mediated renal damage.
renal TGF-1 gene expression showed a positive predictive
To test the hypothesis that infiltrating T cells may ac-value of 90% and a negative predictive value of 88% to identify
tively contribute to the glomerular injury in either MCDFSGS (P  0.0001).
Conclusion. These results support the notion that immuno- or FSGS, we studied the intrarenal transcription of nu-
logically mediated events contribute to the progressive renal merous T cell-related chemokines, cytokines and CTL
damage seen in children with FSGS. effectors in renal biopsy tissue from children with pri-
mary nephrotic syndrome.
Key words: nephrotic syndrome, gene expression, transforming growth
factor-1, cytotoxic T-cells, pediatric nephrology, polymerase chain METHODS
reaction.
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(N  7), IgM nephropathy (N  7), FSGS (N  20), gene expression was normalized for transcription of glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH) aslupus nephritis (N  10, one WHO type 3, 8 WHO type
4, one WHO type 5), or others (membranous, membra- previously described [12].
Data were analyzed with regard to histopathologicalnoproliferative or IgA nephropathy or acute tubular ne-
crosis, N  9) based on the morphological lesion. Fifty- diagnosis, persistent proteinuria or remission, progres-
sive renal failure and response to treatment, namely ste-one proteinuric patients were classified further as steroid
sensitive (SS, N  14) if they responded to an eight- roids. The molecular investigators were blinded to the
results of the histopathologic evaluation, and data wereweek course of steroids given according to the ISKDC
protocol, or steroid resistant (SR, N  39). At the time combined by an independent observer. An unpaired Stu-
dent t test was used to compare numerical data with aof renal biopsy 40 patients were nephrotic, 10 were in
remission and 3 had advanced renal failure. In patients Gaussian distribution, a Mann-Whitney test to analyze
nonparametric data.in remission biopsies were done to assess the need for
continuing therapy. Two patients with MCD later pro-
gressed to SR-NS with biopsy proven FSGS.
RESULTS
At the time of biopsy the patients with lupus nephritis
RNA isolation by silica-based columns proved to bewere receiving monthly pulses of cyclophosphamide and
a fast and effective means to process snap-frozen biopsydaily prednisone at a mean dose of 20 mg/day. Of all
specimens for RT-PCR analysis. Competitive PCR re-patients who were nephrotic and SR, 12 were receiving
sults showed a mean amount of 55  69 pg of GAPDHCsA at a mean dose of 8 mg/kg/day, one tacrolimus and
cDNA (mean  SD) per sample. Only one sample withseven alternating steroids. In SS NS, five patients were
less than 0.1 pg/L GAPDH cDNA (4 pg total) wasreceiving prednisone at the time of biopsy, one received
excluded from further analysis.CsA continuously.
No transcripts for IL-2 or IL-4 were found in any of
the specimens regardless of the diagnosis and the degreeBiopsies
of nephrosis. IL-7 mRNA was observed in low levels ofRenal tissue was obtained by percutaneous biopsy in
less than 3 ag/pg GAPDH in only 7 of 52 specimens (6all patients using either a 15 or 18 gauge biopty needle.
FSGS and 1 membranoproliferative glomerulonephritis,Renal biopsy was performed in all patients for diagnostic
Table 1). IL-15 was completely absent in 9 specimenspurposes, after informed permission was obtained from
(5 FSGS, 1 MCD, 2 IgM and 1 lupus nephritis; Table 1)one parent or guardian and informed assent was ob-
and detectable at an average of 0.059  0.033 pg/pgtained from the patient when the child was over 12 years
GAPDH in the remaining samples without significantold. Two cores of tissue were obtained. One core was
differences in FSGS, IgM and MCD. Patients with lupussubmitted to the pathology lab for morphological diag-
nephritis showed a nonsignificant trend to less IL-15nosis. The other core was placed into a 1 mL NUNC
gene expression as other nephrotic patients (0.017 cryo tube, sealed and the specimen was immediately
0.012 pg/pg GAPDH, P  0.11) The magnitude of ex-snap frozen in liquid nitrogen, and stored at 70C and
pression of IL-15 transcripts in NS biopsies is less thanshipped, on dry ice, to the molecular laboratory for gene
that previously observed in normal renal tissue or intranscript analysis.
renal allograft dysfunction without rejection (0.085 
Methodology for gene transcript studies 0.037, P  0.015, t test) [12]. No differences were ob-
served between SS and SR patients and in specimens ob-Intrarenal gene expression of T cell-related cytokines
tained from both steroid treated and untreated patients.[interleukin-2 (IL-2), IL-4, IL-7, IL-15, IL-17], the -chain
Interleukin-2 receptor alpha mRNA (IL-2R) was de-of the IL-2 receptor, chemokines RANTES and IL-8, cy-
tected in 24 of 42 patients in relapse and in 6 of 11totoxic effector molecules (Fas-ligand, granzyme B, and
patients in remission. Biopsies positive for IL-2R wereperforin) and transforming growth factor-1 (TGF-1)
seen in patients with FSGS (14 of 20), lupus nephritiswas studied in homogenized specimens utilizing reverse
(3 of 10), IgM nephropathy (5 of 7), MCD (5 of 7), andtranscription-assisted–polymerase chain reaction (RT-
in 3 of 9 other patients. When samples were evaluatedPCR) methods and primers previously described by our
with regard to the patients’ steroid response, IL-2Rgroup in renal transplantation [12]. RNA isolation was
mRNA was present in 22 of 39 SR patients and 7 of 14performed by a modified version of a silica-column based
SS patients at the time of biopsy.method (RNEasy; Qiagen, Hilden, Germany) proven
Interleukin-8 and RANTES transcripts were observedto give comparable yields as Caesium chloride based
in low frequency in both FSGS and MCD patients with-RNA extraction in transplant biopsies (Strehlau, unpub-
out significant differences with regard to disease, steroidlished observations). Target gene amplification by PCR
response or proteinuria (Table 1). IL-17 transcription waswas first performed nonquantitatively. Semiquantitative
evaluation performed in specimens positive for a target not detectable in any of the specimens evaluated.
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Table 1. Patient diagnoses
Disease Proteinuria Response to steroids
IgM MCD FSGS Lupus Other Total/pos Nephrotic Remission Sensitive Resitant
N 7 7 20 10 8 45 40 10 11 39
Cytokines
IL-2 0 0 0 0 0 0 0 0 0 0
IL-2R 5 5 14 3 3 25 19 6 7 22
IL-4 0 0 0 0 0 0 0 0 0 0
IL-7 0 0 6 0 0 7 7 0 0 7
IL-15 5 6 15 9 8 38 6 30
IL-17 0 0 0 0 0 0 0 0 0 0
Chemokines
IL-8 1 2 2 0 1 5 3 2 2 3
RANTES 0 2 4 0 1 7 4 3 3 4
Cytotoxic effectors
GranzB 1 2 8 2 0 12 9 3 0 12
Perf 2 1 7 1 2 11 9 2 0 10
FasL 2 2 12 3 4 21 15 6 1 20
Others
TGF-1 2 1 18 0 0 19 19 0 3 33
Fig. 1. Intrarenal gene expression of transforming growth factor-1 (TGF-1; ), Fas-ligand (), granzyme B ( ), and perforin () in ne-
phrotic children according to histological criteria. Two children with MCD showing transcription of TGF-1 and Fas-ligand later progressed to FSGS.
Intrarenal gene expression of cytotoxic T-lymphocyte only detectable in those two children whose lesions later
progressed to FSGS.mediators and TGF-1 was preferentially noted in chil-
FasL tended to be coexpressed with TGF-1, granzymedren with progressive disease leading to chronic renal
B and perforin in steroid-resistant NS regardless of thefailure (Figs. 1 and 2). TGF-1 gene expression was
histological diagnosis. In 22 biopsies from SR patientsdetectable in 18 of 20 FSGS patients as compared to
positive for Fas-ligand transcripts, 17 showed TGF-1,only 2 MCD and 3 IgM patients (P  0.001, Mann–
13 granzyme B and 9 perforin gene expression. In con-Whitney test). TGF-1 transcripts were noted in 23 of
trast, in the remaining 17 children with SR-NS negative29 children with SR-NS not caused by lupus nephritis as
for intrarenal Fas-ligand transcripts, 8 showed TGF-1,compared to 3 of 10 with steroid responsive NS (P 
5 granzyme B, and 2 perforin gene expression (P  NS).0.001, Mann–Whitney). All 10 children with lupus ne-
TGF-1-transcripts in FasL negative samples were solelyphritis were negative for TGF-1. In SR NS not caused
detectable in FSGS patients.by lupus nephritis, intrarenal TGF-1 gene expression
showed a positive predictive value of 90% and a negative
DISCUSSIONpredictive value of 80% to identify FSGS compared to
any other lesion (P  0.001, 	2). A combined intrarenal Both the cascade of events leading to progressive col-
lapse and scarring of the glomeruli in FSGS and the tar-gene expression of TGF-1 and Fas-ligand in SS NS was
Strehlau et al: CTL effectors and TGF-b1 in FSGS 93
Fig. 2. Intrarenal gene expression of TGF-1 ( ), Fas-ligand (), granzyme B ( ), and perforin () in nephrotic children according to treatment
response. Two steroid-sensitive (SS) patients positive for TGF-1 transcription later became steroid resistant (SR).
Fig. 3. Treatment efficacy in children with
steroid-resistant nephrotic syndrome with re-
gard to gene expression of Fas-ligand. Patients
positive for intrarenal FasL transcription show
a favorite response to treatment less often as
compared to Fas-ligand patients.
get for a recently described circulating proteinuric factor T-cell growth factors
in FSGS [13] remain unknown. The tendency of childhood T-cell growth factors, namely IL-2 and its alpha recep-
NS to manifest and relapse after viral infections and al- tor (IL-2R), have been incriminated in NS. Injection
lergy, its association with HLA DR antigens, and thera- of recombinant IL-2 induces proteinuria in rats in a dose
peutic response to steroids and immunosuppressive drugs dependent manner [20] and administration of human
such as CsA and cyclophosphamide suggest a possible IL-2 in cancer chemotherapy causes massive proteinuria
role for an immune mediated pathogenesis, whereas oth- that resolves after the administration is discontinued
ers advocate that FSGS lesions may only be a common [21]. Furthermore, injected IL-2 has been shown to in-
unspecific pathway of various injuring mechanisms [14]. duce fusion of epithelial foot processes in a rat model
Neither circulating nor in situ immune complexes have [22]. However, according to our study T cells infiltrating
been consistently demonstrated in patients with NS, and a nephrotic kidney do not show enhanced transcription
peripheral blood counts of CD4
 and CD8
 lymphocytes of IL-2 or any other alternative T cell activating cytokine
remain unaltered [15]. However, renal antigens are rec- such as IL-7, IL-15 or IL-17. IL-15 transcription below
ognized by T cells from nephrotic patients with MCD and those amounts detectable in unaffected transplanted kid-
FSGS and induce a cytokine release [16]. More recently, neys [12] oppose a role for this transcription-regulated
increased infiltration of both CD4
 and CD8
 lympho- cytokine, although the gene transcription rate in normal
cytes has been shown in FSGS as compared to normal human kidneys remains to be established. Transcription,
kidneys and MCD [17]. Among the immunological medi- detectable in all of the diseases studied, is not informative
ators demonstrated to be present in the peripheral blood with regard to relapse and remission or steroid response.
of patients with NS during an episode of relapse are
Chemokinestumor necrosis factor- (TNF-) [18] IL-2 [7, 8], IL-6
[19], IL-8 [9] and TGF-1. Although many of these medi- More recently chemokines have been implicated in
ators are known to be present in blood during or past idiopathic NS and other glomerulopathies. Garin et al
an infection, few studies have addressed the intrarenal have demonstrated that the expression of IL-8 mRNA
and protein in peripheral blood strongly correlated withexpression of these mediators in clinical NS.
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nephrotic relapses in MCD and that neutralizing anti- techniques quantifying transcripts in homogenized sam-
bodies against IL-8 counteract the uptake of 35SO4 into ples are unable to assign a transcription rate to a specific
the extracellular matrix [9]. Intrarenal expression of cell type. The cellular origin of the observed transcripts
MCP-1 but not RANTES has been reported experimen- therefore needs to be evaluated.
tal rat nephrosis [23]. Positive RANTES and IL-8 gene In summary, our study strongly supports the notion
expression in primary NS is less frequent than recently of immunologically mediated events in nephrotic kid-
reported in recurrent FSGS [24]. neys and points to several previously unknown phenom-
ena. (1) Children with NS, namely FSGS, show active
Tissue growth factors intrarenal transcription of TGF-1, CTL effectors and
Expression of tissue growth factors [TGF-1 through to a lesser degree chemokines. This transcription is less
TGF-3, platelet-derived growth factor (PDGF), fibro- pronounced in MCD. (2) There is no sign of intrarenal
blast growth factor (FGF), epidermal growth factor T cell growth factor (IL-2, IL-7 and IL-15) pathway acti-
(EGF)] has been associated with proliferative and/or vation. (3) TGF-1 gene transcription and—to a lesser
fibrotic lesions in glomerulopathies. TGF-1 mRNA is degree CTL effectors—seem to be indicative of progres-
induced in animal models of focal glomerulosclerosis due sive renal damage typical of FSGS, while such transcripts
to puromycin [25] and in vivo transfection of TGF-1 and are rarely observed in MCD. (4) The anecdotal observa-
PDGF-B induces glomerulosclerosis [26], while TGF-1 tion, that MCD patients with TGF-1 and fas-ligand
knockout mice do not develop such lesions. Kanai et al expression later developed histological signs of FSGS,
noted a tenfold increase in urinary TGF-1 excretion in needs further substantiation in a larger cohort. (5) Since
adult patients with FSGS compared to in controls [27] calcineurin inhibitors can up-regulate TGF-1 transcripts,
and Murakami et al, confirming such results in nephrotic we are now studying renal biopsy tissue for TGF-1 gene
children, showed a correlation between urinary TGF-1 transcripts prior to the initiation of cyclosporine therapy,
levels and the grade of interstitial fibrosis [28]. Yama- and suggest that this be done by other investigators as
moto and colleagues report a marked increase of all three well.
TGF- isoforms in immunohistology in patients with
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York Medical College, 19 Brahurst Avenue, Box 10, Hawthorne, New
Our study indicates that the intrarenal transcription York 10532, USA.
of TGF-1 is enhanced in patients with FSGS compared E-mail: Atejani@aol.com
to other proteinuric diseases in childhood, and that it
may indicate a less favorable response to steroids and REFERENCES
even an impaired prognosis, if lupus nephritis can be 1. White R: Clinicopathological study of nephrotic syndrome in child-
excluded. It should be noted that 11 of 20 FSGS patients hood. Lancet 1:1353–1359, 1970
2. Warady BA, Hebert D, Sullivan EK, et al: Renal transplantation,in our study were on CsA therapy, which has been shown
chronic dialysis, and chronic renal insufficiency in children andto stimulate TGF-1 expression [30]. However, TGF-1 adolescents. The 1995 Annual Report of the North American Pedi-
gene transcripts also were seen in FSGS patients not atric Renal Transplant Cooperative Study. Pediatr Nephrol 11:49–
64, 1997receiving cyclosporine. In addition, steroids have been
3. Grupe WE: Minimal change disease. Semin Nephrol 2:241–252, 1991shown to stimulate TGF-1 expression [31], and yet 4. Rennke HG: How does glomerular epithelial cell injury contribute
TGF-1 mRNA was not demonstrated in MCD or IgM to progressive glomerular damage? Kidney Int 45(Suppl 45):S58–
S63, 1994nephropathy patients receiving steroids. Post-transcrip-
5. Niaudet P, Fuchshuber A, Gagnadoux MF, et al: Cyclosporinetional regulation has to be taken in account when inter-
in the therapy of steroid-resistant idiopathic nephrotic syndrome.
preting TGF-1 data. Kidney Int 51(Suppl 58):S85–S90, 1997
6. Shalhoub RJ: Pathogenesis of lipoid nephrosis: A disorder of
T-cell function. Lancet 2:556–560, 1974Cytotoxic T-lymphocyte
7. Tejani AT, Butt K, Trachtman H, et al: Cyclosporine A induced
Few data are available on a potential role of CTL in remission of relapsing nephrotic syndrome in children. Kidney Int
NS. Markovic-Lipkovsky et al report a considerable re- 33:729–734, 1988
8. Hulton SA, Shah V, Byrne MR, et al: Lymphocyte subpopula-nal infiltration of CD8
T-cells in FSGS (17) and Orman
tions, interleukin-2 and interleukin-2 receptor expression in child-et al have shown the development of NS in a CD8
 hood nephrotic syndrome. Pediatr Nephrol 8:135–139, 1994
leukemia, which resolved after chemotherapy [32]. No 9. Garin EH, Blanchard DK, Matsushima K, et al: IL-8 production
by peripheral blood mononuclear cells in nephrotic patients. Kid-data are available intrarenal CTL effector molecule gen-
ney Int 45:1311–1317, 1994eration in childhood NS thus far. Our data, to our knowl-
10. Bock G, Ongkingco J, Patterson L, et al: Serum and urine soluble
edge for the first time, indicate a substantial intrarenal interleukin-2 receptor in idiopathic nephrotic syndrome. Pediatr
Nephrol 7:523–528, 1993transcription of Fas-ligand, granzyme B and perforin.
11. Kemper M, Meyer-Jark T, Strehlau J, et al: Soluble interleukin-Although the numbers are still small, CTL gene expres-
2-receptor (sIL2-R) in steroid responsive nephrotic syndrome of
sion in childhood NS seems to correlate with FSGS and childhood. Pediatr Nephrol C36, 1994
12. Strehlau J, Pavlakis M, Lipman M, et al: Quantitative detectionthe severity of disease in primary NS. However, PCR
Strehlau et al: CTL effectors and TGF-b1 in FSGS 95
of immune activation genes as a diagnostic tool in kidney trans- moattractant protein-1 in experimental nephrotic syndrome. Clin
Immunol Immunopathol 78:140–151, 1996plantation. Proc Natl Acad Sci USA 94:696–700, 1997
24. Strehlau J, Pavlakis M, Vasconcellos L, et al: Patterns of intra-13. Savin VJ, Sharma R, Sharma M, et al: Circulating factor associated
graft cytokine gene expression in recurrent focal segmental glomer-with increased glomerular permeability to albumin in recurrent focal
ulosclerosis after renal transplantation. Pediatr Nephrol 10:C73, 1996segmental glomerulosclerosis. N Engl J Med 334:878–883, 1996
25. Nakamura T, Ebihara I, Fukui M, et al: Messenger RNA expres-14. Shirato I, Hosser H, Kimura K, et al: The development of focal
sion for growth factors in glomeruli from focal glomerular sclerosis.segmental glomerulosclerosis in masugi nephritis is based on pro-
Clin Immunol Immunopathol 66:33–42, 1993gressive podocyte damage. Virchows Arch 429:255–273, 1996
26. Isaka Y, Fujiwara Y, Ueda N, et al: Glomerulosclerosis induced by15. Fiser RT, Arnold WC, Charlton RK, et al: T-lymphocyte subsets in vivo transfection of transforming growth factor-beta or platelet-
in nephrotic syndrome. Kidney Int 40:913–916, 1991 derived growth factor gene into the rat kidney. J Clin Invest 92:
16. McFarlane H, Orr WM, Taylor G: Cell mediated immunity in 2597–2601, 1993
nephrotic syndrome. Lancet 1:507–509, 1972 27. Kanai H, Mitsuhashi H, Ono K, et al: Increased excretion of
17. Markovic-Lipkovski J, Muller CA, Risler T, et al: Association urinary transforming growth factor beta in patients with focal glo-
of glomerular and interstitial mononuclear leukocytes with different merular sclerosis. Nephron 66:391–395, 1994
forms of glomerulonephritis. Nephrol Dial Transplant 5:10–17, 1990 28. Murakami K, Takemura T, Hino S, Yoshioka K: Urinary trans-
18. Suranyi M, Guasch A, Hall B, Myers B: Elevated levels of forming growth factor- in patients with glomerular diseases. Pedi-
atr Nephrol 11:334–336, 1997tumor necrosis factor-alpha in the nephrotic syndrome in humans.
29. Yamamoto T, Noble N, Cohen A, et al: Expression of transformingAm J Kidney Dis 21:251–259, 1992
growth factor- isoforms in human glomerular diseases. Kidney19. Horii Y, Muraguchi A, Iwano M, et al: Involvement of IL-6 in
Int 49:461–469, 1996mesangial proliferative glomerulonephritis. J Immunol 143:3949–
30. Li B, Sehajpal PK, Khanna A, et al: Differential regulation of3955, 1989
transforming growth factor beta and interleukin 2 genes in human20. Heslan J, Pivotsky E, Evanellec A, Lagrue G: Recombinant
T cells: Demonstration by usage of novel competitor DNA con-IL-2 induced proteinuria into isolated perfused rat kidney. Prog
structs in the quantitative polymerase chain reaction. J Exp MedBasement Membr Res 19:277, 1988 174:1259–1262, 1991
21. Hisanaga S, Kawagoe H, Yamamoto Y, et al: Nephrotic syndrome 31. Ayanlar-Batuman O, Ferrero A, Diaz A, Jimenez S: Regulation
associated with recombinant interleukin-2. Nephron 54:140–146, of transforming growth factor-1 gene expression by glucocorticoids
1990 in normal human T-lymphocytes. J Clin Invest 88:1574–1580, 1991
22. Rosenstein M, Ettinghausen S, Rosenberg S: Extravasation of 32. Orman SV, Schechter GP, Whang-Peng J, et al: Nephrotic syn-
intravascular fluid mediated by the systemic administration of re- drome associated with a clonal T-cell leukemia of large granular
combinant interleukin-2. J Immunol 137:1735–1742, 1986 lymphocytes with cytotoxic function. Arch Intern Med 146:1827–
1829, 198623. Eddy AA, Warren JS: Expression and function of monocyte che-
